Weiss Multi-Strategy Advisers’s Envoy Medical COCH Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio COCH Stock Details COCH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-27,058	Closed	-$271K	–	640
2022 Q4	$271K	Sell	27,058 -11,398	-30%	-$113K	0.01%	535
2022 Q3	$378K	Hold	38,456	–	–	0.01%	569
2022 Q2	$377K	Hold	38,456	–	–	0.01%	566
2022 Q1	$376K	Hold	38,456	–	–	0.01%	586
2021 Q4	$375K	Hold	38,456	–	–	0.01%	573
2021 Q3	$373K	Buy	+38,456	New	+$372K	0.01%	585

Other funds holding COCH

AMC

Atlas Merchant Capital New York $789K AUM 60.67% 1-Year Est. Return

SIM

Sandia Investment Management Boston, Massachusetts $40.1M AUM 14.58% 1-Year Est. Return

Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

KPF

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Weiss Multi-Strategy Advisers's COCH Position: Q1 2023 in Review

Weiss Multi-Strategy Advisers sold out of Envoy Medical (COCH) in Q1 2023, closing a stake of 27,058 shares — an estimated $271K sold.

Weiss Multi-Strategy Advisers first reported a position in COCH in Q3 2021 and held it in 6 quarters. The position peaked at $378K in Q3 2022. 24 funds tracked by Wall St. Rank hold COCH as of Q1 2023.

Weiss Multi-Strategy Advisers reported no remaining Envoy Medical position as of Q1 2023 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 27,058 Envoy Medical shares in Q1 2023, an estimated $271K.
Weiss Multi-Strategy Advisers first reported a position in Envoy Medical in Q3 2021 and held it in 6 quarters.
Weiss Multi-Strategy Advisers's Envoy Medical position peaked at $378K in Q3 2022.
24 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2023.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2023, filed 15 May 2023.